Dirlotapide
Dirlotapide is a drug used to treat obesity in dogs. It is manufactured by Pfizer and marketed as Slentrol.
It works as a selective microsomal triglyceride transfer protein inhibitor. This blocks the assembly and release of lipoproteins into the bloodstream, thereby reducing fat absorption. It also elicits a satiety signal from lipid-filled cells lining the intestine.
It is supplied as an oral solution. It is not intended for use in humans or cats.
On January 5 2007, the FDA approved Slentrol, the first time the FDA has approved a drug for obese dogs.[1]
External links
References
- ↑ "FDA approves 1st drug for obese dogs". Yahoo. Retrieved 2007-01-06.